Swiss Life Holding


Solid H1 20 figures, all targets confirmed despite COVID-19

13/08/20 -"• Net profit attributable to shareholders decreased by 13% to CHF533m for H1 20 • Gross written premiums were down by 17% for H1 20 due to a special Swiss effect in 2019 but +2% on an adjusted ..."

Pages
45
Language
English
Published on
13/08/20
You may also be interested by these reports :
21/01/26
Mapfre’s share price fell sharply on Tuesday following the group’s pre-close call. While management indicated that underlying trends remained ...

19/01/26
Zurich has announced that it has submitted a proposal to the board of Beazley (not covered) to acquire 100% of the company at 1,280p per share. This ...

13/01/26
The battle for power at the helm of Generali could take yet another turn, following press reports that UniCredit has discussed the potential ...

05/01/26
Since our last Teaser on Swiss Re (REDUCE ; Switzerland), one year ago, much has changed — not only for the group itself, but also more broadly ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO